SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-033962
Filing Date
2023-10-05
Accepted
2023-10-05 16:05:27
Documents
15
Period of Report
2023-10-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20231005.htm   iXBRL 8-K 28480
2 EX-1.1 exhibit11-closing8xk.htm EX-1.1 260349
3 EX-5.1 exhibit51-closing8xk.htm EX-5.1 25144
7 maplesgroupa.jpg GRAPHIC 90430
  Complete submission text file 0001628280-23-033962.txt   624933

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20231005.xsd EX-101.SCH 1922
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20231005_lab.xml EX-101.LAB 24801
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20231005_pre.xml EX-101.PRE 13045
9 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20231005_htm.xml XML 2802
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 231311368
SIC: 2834 Pharmaceutical Preparations